Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Megakaryoblastic, Acute

Explore clinical trials studying Leukemia, Megakaryoblastic, Acute. Study availability and eligibility vary by location and protocol.

127 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Megakaryoblastic, Acute trial results

Completed

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00093470

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente-San Diego Mission San Diego, California, United States
View all 341 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02085408

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 269 locations
View Trial Details
Completed

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

NCT00046930

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 92 locations
View Trial Details
Completed

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

NCT00005962

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 65 locations
View Trial Details
Completed

Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01154439

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy
  • Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Naples, Italy
  • Università La Sapienza Roma, Italy
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy
View Trial Details

Related conditions